The global blood screening market, valued at USD 3.40 billion in 2024, is projected to expand at a compound annual growth rate (CAGR) of 11.9% from 2025 to 2030. This anticipated growth is largely due to a global increase in blood donations, which heightens the need for rigorous screening processes to detect transfusion-transmissible infections and ensure patient safety. Advances in technology,...

The Europe blood screening market size is expected to reach USD 1,954.8 million by 2030, registering a CAGR of 11.2% from 2023 to 2030, according to a new report by Grand View Research, Inc. Increasing number of blood transfusion processes performed along with stringent regulations in Europe mandating screening tests, such as NAT for testing HIV, HBV, and HCV, is contributing to the...